Fibrosis is the formation of excess fibrous connective tissue in an organ or tissue in a reparative or reactive process. This results from the hyperproliferation and motility of fibroblasts, in turn leading to the deposition of excess extracellular matrix proteins. Fibrosis can be a reactive, benign, or pathological state. In the pathological state, fibrosis obliterates the architecture and function of the underlying organ or tissue. Though there are currently very few effective means of treating fibrosis, our preclinical studies suggest that MicroCures Inhibitor technology can be utilized to limit or abolish fibrosis in various tissues and organs.